Wealth Way Finder
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Wealth Way Finder

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025
May 12, 2025
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Multiple New Multi-Commodity Targets
next post
House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’

Related Posts

5 Top Weekly TSXV Stocks: Bluestone Resources Shines...

January 22, 2024

Forward Water Technologies Announces Commercial Update

June 1, 2024

Crescent Point Deal and TMX Completion Fuel Activity...

May 8, 2024

Strategic Resources Engages Lead Bank for its Construction...

July 25, 2024

Sona Nanotech

June 28, 2024

Exclusive Interview with Forward Water Technologies CEO Howie...

November 16, 2024

How to Invest in Potash (Updated 2024)

April 11, 2024

Brunswick Exploration Starts Winter Drilling Campaign at Mirage

January 23, 2024

Canadian Critical Minerals

May 24, 2024

Panelists Tout Copper’s Long-term Fundamentals — Is Now...

February 6, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,124)
    • Investing (1,915)
    • Politics (2,503)
    • World (2,513)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: wealthwayfinder.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 wealthwayfinder.com | All Rights Reserved